FIELD: medicine.
SUBSTANCE: invention refers to using Imidafenacin for intensifying antidiuretic action of vasopressin or desmopressin.
EFFECT: invention provides intensifying antidiuretic action of vasopressin or agonist V2-receptor vasopressin (desmopressin) and can be used in a method for preventing or treating pollakiuria and nocturia, particularly nocturia caused by nighttime polyuria.
1 cl, 4 ex, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
CONDENSED AZEPINES, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, METHOD FOR TREATMENT BY USING INDICATED COMPOSITION | 2001 |
|
RU2259367C2 |
METHODS AND DEVICES FOR DESMOPRESSIN PREPARATION DELIVERY | 2008 |
|
RU2472539C2 |
BICYCLIC AGONISTS OF VASOPRESSIN | 2000 |
|
RU2254332C2 |
MAINTENANCE AND CORRECTION METHOD OF WATER-ELECTROLYTIC BALANCE IN MAMMALS | 2007 |
|
RU2342100C1 |
METHOD FOR SCREENING AND DIFFERENTIAL DIAGNOSIS OF NOCTURIA | 2020 |
|
RU2759783C1 |
MAINTENANCE AND CORRECTION METHOD OF WATER-ELECTROLYTIC BALANCE IN PRIMATES | 2007 |
|
RU2342101C1 |
SAFE APPLICATION OF DESMOPRESSINUM | 2010 |
|
RU2569756C2 |
METHOD OF TREATING CHILDREN WITH OVERACTIVE BLADDER | 2014 |
|
RU2585727C1 |
METHOD OF TREATING PATIENTS AGED 14-17 WITH ENURESIS | 2023 |
|
RU2820167C1 |
NEW POLYMORPH | 2011 |
|
RU2559633C2 |
Authors
Dates
2020-05-29—Published
2016-12-22—Filed